In the current health care landscape, the exorbitant cost of prescription drugs has become a significant concern for millions of Americans, particularly those enrolled in Medicare. The potential solution to this issue lies in the power of Medicare to directly negotiate drug prices, given its massive base of over 65 million enrollees. But what if Medicare did negotiate directly? What impact would it have on drug costs? Empowering Medicare to negotiate drug prices could unlock affordability all around, ensuring Medicare beneficiaries receive affordable access to the medications they need. Or it might not. Let’s explore the government’s attempt through the Inflation Reduction Act to make Medicare drug prices more affordable through negotiations. WHAT IS THE INFLATION REDUCTION ACT? The Inflation Reduction Act of 2022, signed into law by President Biden, introduces significant changes to address this challenge. One essential part empowers the Health and Human Services Secretary to negotiate drug prices for Medicare Part D, departing from the previous non- interference clause that restricted these negotiations. WHAT DOES THIS ACT MEAN FOR MEDICATION PRICING? This Act delivers strict penalties to pharmaceutical companies that increase prices beyond the inflation rate, adding a layer of accountability to curb rising drug costs. Specific drugs have been targeted for negotiation based on their substantial contribution to Medicare Part D spending. Insulin prices, a critical concern for those with diabetes, are capped at $35. This will offer much-needed relief during deductible and coverage gaps. WHAT ARE THE DRAWBACKS? Despite these positive steps, the road to affordable drug prices faces challenges. Pharmaceutical companies contest the government’s authority, citing overreach, and threaten legal action. The effectiveness is under scrutiny, with delays and reversals looming. Various market forces, like upcoming patent expirations, could lead to lower drug prices, potentially overshadowing government intervention. The exclusivity of certain drugs, like Januvia and Farxiga, is expected to end. This can create opportunities for more cost-effective generic versions, reducing the cost of those medications. We know every penny counts! Whether through government intervention, expiration of patents, or market forces, medication prices are trending downward. These changes can be widely beneficial for you. Hence, it’s vital to thoroughly evaluate your plan annually to ensure you have the best Medicare plan based on your needs and budget. THE PURSUIT OF AFFORDABLE MEDICATION FOR BENEFICIARIES NAVIGATING THE FUTURE
Testimonial “The Medicare decision process was overwhelming for me. Chris and Angi did an exceptional job of laying out pros and cons for each option and patiently listened to my concerns and answered my questions. I never felt pressured
to make a decision or steered in a direction that I was not 100% comfortable with. I trust Chris and would not hesitate to recommend Omaha Insurance Solutions to my family and friends.” –Paula K
Puff Pastry Berry Hearts
Inspired by Weelicious.com
Valentine’s Day means heart-shaped everything, even desserts! Bake these puff pastry berry hearts for Valentine’s Day or any other day. Ingredients • 1 package frozen puff pastry, defrosted • 1 tsp powdered sugar
• 1/2 cup fresh
• 1 cup heavy cream
raspberries (or berries of your choice)
Directions 1. Preheat oven to 400 F. Unfold the puff pastry and use a heart-shaped cookie cutter to cut into heart shapes. 2. On a baking sheet, place puff pastry hearts and bake for 10–12 minutes or until golden brown. 3. In a standing mixer, whip the cream on medium-high speed for 2–3 minutes. Add the powdered sugar and beat on high for 30 more seconds or until thick and fluffy. 4. Remove hearts from the oven and allow to cool completely. Slice each heart in half between pastry layers to create 2 hearts. Top the bottom half with whipped cream and berries, and place the other half on top to form a sandwich.
402-614-3389 • 3
Made with FlippingBook Ebook Creator